Type 2 diabetes patients who had steady blood glucose control over six years were more likely to live longer than those who had more A1C variability, according to findings presented at the European Association for the Study of Diabetes annual meeting. Researchers examined up to 21,000 patients from Scotland and found that an A1C variability of 60% or higher was tied to an increased risk for chronic kidney disease, heart disease, heart failure, nerve damage and stroke, as well as a higher risk for diabetic eye disease and diabetic foot ulcer.
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.